• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

AMS to show Aurora with FDA clearance

Article

Advanced Mammography Systems will enjoy its first RSNA meetingwith 510(k) clearance for its Aurora 0.5-tesla dedicated MR mammographyscanner, which it is marketing at a list price of about $500,000.AMS, of Wilmington, MA, received the Food and Drug

Advanced Mammography Systems will enjoy its first RSNA meetingwith 510(k) clearance for its Aurora 0.5-tesla dedicated MR mammographyscanner, which it is marketing at a list price of about $500,000.AMS, of Wilmington, MA, received the Food and Drug Administration'simprimatur in February, and the first beta unit was installedat the Breast Imaging Center at the University of Texas MedicalBranch in Galveston. That center has examined over 200 women withthe system, AMS reported last month.

Aurora is an important part of a new corporate strategy adoptedearlier this year by AMS parent Advanced NMR Systems, which wasforced to shut down its InstaScan echo-planar imaging effort dueto slow sales (SCAN 6/19/96). Advanced NMR intends to open a networkof Aurora Breast Imaging centers to offer MR mammography services.The first such center will be installed in early 1997 at the Faulkner-SagoffCentre for Breast Health Care at Faulkner Hospital in Boston.

Related Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.